Tracy A. Becerra-Culqui
Research Subjects
Tracy A. Becerra-Culqui has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Ashli A. Owen-Smith
Division of Health Management and Policy, Georgia State University, Atlanta, USA
1 shared publication- Ashli A. Owen-Smith
Georgia State University, Atlanta, USA.
1 shared publication - Cathleen Yoshida
Kaiser Permanente Northern California Division of Research 2000 Broadway, Oakland, CA 94612, United States
1 shared publication Darios Getahun
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California
1 shared publicationFrances L. Lynch
Kaiser Permanente Center for Health Research, Portland, USA
1 shared publication- Frances L. Lynch
Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon
1 shared publication
Latest Publications
- Open Access
- 1 September 2018
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 142 (3) , e20180120
Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder
BACKGROUND: Increasing vaccination of pregnant women makes it important to assess safety events potentially linked to prenatal vaccination. This study investigates the association between prenatal tetanus, diphtheria, acellular pertussis (Tdap) vaccination and autism spectrum disorder (ASD) risk in offspring. METHODS: This is a retrospective cohort study of mother-child pairs with deliveries January 1, 2011 to December 31, 2014 at Kaiser Permanente Southern California hospitals. Maternal Tdap vaccination from pregnancy start to delivery date was obtained from electronic medical records. A diagnosis of ASD was obtained by using International Classification of Diseases, Ninth and Tenth Revision codes. Children were managed from birth to first ASD diagnosis, end of membership, or end of follow-up (June 30, 2017). Cox proportional hazards models estimated the unadjusted and adjusted hazard ratios (HRs) for the association between maternal Tdap vaccination and ASD, with inverse probability of treatment weighting to adjust for confounding. RESULTS: Women vaccinated were more likely to be Asian American or Pacific Islander, be nulliparous, have a higher education, receive influenza vaccination prenatally, and give birth at term. ASD was diagnosed in 1341 (1.6%) children, and the incidence rate was 3.78 per 1000 person years in the Tdap exposed and 4.05 per 1000 person years in the unexposed group (HR: 0.98, 95% confidence interval: 0.88–1.09). The inverse probability of treatment weighting–adjusted analyses revealed that prenatal Tdap vaccination was not associated with an increased ASD risk (HR: 0.85, 95% confidence interval: 0.77–0.95). CONCLUSIONS: Prenatal Tdap vaccination was not associated with an increased ASD risk. We support recommendations to vaccinate pregnant women to protect infants, who are at highest risk of death after pertussis infection.
- 1 September 2018
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 142 (3) , e20180120
Open AccessPrenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination and Autism Spectrum Disorder
BACKGROUND: Increasing vaccination of pregnant women makes it important to assess safety events potentially linked to prenatal vaccination. This study investigates the association between prenatal tetanus, diphtheria, acellular pertussis (Tdap) vaccination and autism spectrum disorder (ASD) risk in offspring. METHODS: This is a retrospective cohort study of mother-child pairs with deliveries January 1, 2011 to December 31, 2014 at Kaiser Permanente Southern California hospitals. Maternal Tdap vaccination from pregnancy start to delivery date was obtained from electronic medical records. A diagnosis of ASD was obtained by using International Classification of Diseases, Ninth and Tenth Revision codes. Children were managed from birth to first ASD diagnosis, end of membership, or end of follow-up (June 30, 2017). Cox proportional hazards models estimated the unadjusted and adjusted hazard ratios (HRs) for the association between maternal Tdap vaccination and ASD, with inverse probability of treatment weighting to adjust for confounding. RESULTS: Women vaccinated were more likely to be Asian American or Pacific Islander, be nulliparous, have a higher education, receive influenza vaccination prenatally, and give birth at term. ASD was diagnosed in 1341 (1.6%) children, and the incidence rate was 3.78 per 1000 person years in the Tdap exposed and 4.05 per 1000 person years in the unexposed group (HR: 0.98, 95% confidence interval: 0.88–1.09). The inverse probability of treatment weighting–adjusted analyses revealed that prenatal Tdap vaccination was not associated with an increased ASD risk (HR: 0.85, 95% confidence interval: 0.77–0.95). CONCLUSIONS: Prenatal Tdap vaccination was not associated with an increased ASD risk. We support recommendations to vaccinate pregnant women to protect infants, who are at highest risk of death after pertussis infection.
- 12 May 2018
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 48 (10) , 3367-3376
Parental First Concerns and Timing of Autism Spectrum Disorder Diagnosis
Specific developmental concerns can distinguish between an early versus later diagnosis of autism spectrum disorder (ASD). Caregiver survey responses of children ≥ 9 years-of-age (2012) with ASD were used to evaluate developmental concerns and associations with age of diagnosis [early (< 3 years: n = 106) vs. later (≥ 3 years: n = 432)] using logistic regression. Concerns arose at mean age 18 and 35-months for children diagnosed early versus later, respectively. Concerns about poor eye contact (aOR 1.81, CI 1.08, 3.05), pointing/gesturing (aOR 2.74, CI 1.60, 4.70), response to own name (aOR 3.03, CI 1.75, 5.23), and babbling/speaking (aOR 1.67, CI 0.98, 2.82) were associated with an early diagnosis. Caregivers and pediatricians are critical in early identification and timely entry into intervention.
- 12 May 2018
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 48 (10) , 3367-3376
Parental First Concerns and Timing of Autism Spectrum Disorder Diagnosis
Specific developmental concerns can distinguish between an early versus later diagnosis of autism spectrum disorder (ASD). Caregiver survey responses of children ≥ 9 years-of-age (2012) with ASD were used to evaluate developmental concerns and associations with age of diagnosis [early (< 3 years: n = 106) vs. later (≥ 3 years: n = 432)] using logistic regression. Concerns arose at mean age 18 and 35-months for children diagnosed early versus later, respectively. Concerns about poor eye contact (aOR 1.81, CI 1.08, 3.05), pointing/gesturing (aOR 2.74, CI 1.60, 4.70), response to own name (aOR 3.03, CI 1.75, 5.23), and babbling/speaking (aOR 1.67, CI 0.98, 2.82) were associated with an early diagnosis. Caregivers and pediatricians are critical in early identification and timely entry into intervention.
- 1 June 2017
- Published by The Permanente Federation in The Permanente Journal
- Vol. 21 (2) , 16-009
A Survey of Parents with Children on the Autism Spectrum: Experience with Services and Treatments
Tracy A Becerra, PhD, OTR/L; Maria L Massolo, PhD; Vincent M Yau, PhD; Ashli A Owen-Smith, PhD; Frances L Lynch, PhD; Phillip M Crawford, MS; Kathryn
- 1 June 2017
- Published by The Permanente Federation in The Permanente Journal
- Vol. 21 (2) , 16-009
A Survey of Parents with Children on the Autism Spectrum: Experience with Services and Treatments
Tracy A Becerra, PhD, OTR/L; Maria L Massolo, PhD; Vincent M Yau, PhD; Ashli A Owen-Smith, PhD; Frances L Lynch, PhD; Phillip M Crawford, MS; Kathryn